Drug Research
UK, India sign deal to support R&D, innovation projects
The Technology Strategy Board (TSB) in the UK and the Indian government's Department of Science and Technology have signed 'Programme of Co-operation' deal to...
Drug Research
ImmBio gets Biomedical Catalyst support to develop pneumococcal vaccine...
Immunobiology (ImmBio), a UK-based biopharmaceutical company, has bagged £0.2m in funding from the UK government-backed Biomedical Catalyst (BBC) for the pre-clinical development of pneumococcal...
Drug Research
Merck, Luminex collaborate to develop companion diagnostic device
Merck, referred to as MSD outside the US and Canada, and Luminex have signed a deal to develop a companion diagnostic device to support...
Drug Research
Mylan Pharmaceuticals launches Fenofibrate Capsules
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. Fenofibrate...
Drug Research
Ablynx inks deal with Spirogen to evaluate novel anti-cancer...
Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As part...
Drug Research
UCB, ConfometRx sign drug discovery research deal
Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the deal,...
Drug Research
Dr. Reddy’s introduces Desloratadine ODT in US
Dr. Reddy's Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets (ODT) in 2.5mg and 5mg strengths in the US. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.